Liminatus Pharma Inc. (LIMN)

Last Closing Price: 3.22 (2026-10-20)

Days Sales in Receivables (Quarterly)

Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover

Liminatus Pharma Inc. (LIMN) Days Sales in Receivables data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
--
$-1.41M
--
--
$1.38M
$-1.38M
$-0.03M
$-1.41M
$-1.41M
$-1.41M
$-1.41M
$-1.41M
$-1.41M
$-1.38M
$-1.38M
0.97M
0.97M
$-1.50
$-1.50
Balance Sheet Financials
$3.39M
$0.01M
$0.01M
$3.40M
$3.04M
--
$0.06M
$3.10M
$0.30M
$0.30M
$0.30M
1.12M
Cash Flow Statement Financials
$-2.99M
--
$5.66M
$0.34M
$3.02M
$2.68M
--
--
--
Fundamental Metrics & Ratios
1.12
--
--
--
4.80
--
--
--
--
--
--
$-2.99M
--
--
--
--
--
--
Days Sales in Receivables
--
-468.14%
-468.13%
-41.34%
-468.13%
$0.27
$-3.08
$-3.08